Samarra medicines achieve a production value of more than one billion dinars
10:07 - 02/10/2019
[You must be registered and logged in to see this link.]
The General Company for the manufacture of medicines and medical supplies in Samarra on Tuesday, the value of production achieved until mid-September last billion and 296 million and 279 thousand Iraqi dinars.
The director of the factory Samarra Mohammed Abdul Qader said in a statement received / information / a copy of it that "the production achieved within the production plan included the implementation of contracts for the Ministry of Health and Environment, including the production of Interstop (Entero-Stop) treatment for severe diarrhea and Hyporic preparation (for the treatment of sufferers of increased The salts are in addition to the production of Dermodin Ointment and Fugidin Cream, as well as the production of the second shipment of the Cephalexin susp 250 preparation contract and part of the first shipment of Amoxycillnsusp250.
He added that "the total value according to the production program set by the company for the month of September last amount to (2) billion and (900) million dinars, which is the production of preparations over the said month."
He stressed that "the company aspires to the arrival of raw materials contracted by the global and sober to begin to produce and strengthen the production program for the coming months and according to contracts with the Ministry of Health and the need of the local market."